Trial Details
RECRUITINGBasic Information
| Clinical ID | c21 |
|---|---|
| Identifier | NCT07373457 |
| Trial Title | A Phase I Study of HW201877 in Healthy Subjects |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Healthy Participants|IBD (Inflammatory Bowel Disease) |
| Interventions | DRUG: HW201877 capsules|DRUG: Placebo |
Participant Information
| Sponsor | Wuhan Humanwell Innovative Drug Research and Development Center Limited Company |
|---|---|
| City | Changchun |
| Country/Region | China |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE1 |
Time Information
| Start Date | 2025-06-26 |
|---|---|
| Primary Completion Date | 2026-03 |
| Completion Date | 2026-03 |